Pliant Therapeutics PLRX Stock
Pliant Therapeutics Price Chart
Pliant Therapeutics PLRX Financial and Trading Overview
| Pliant Therapeutics stock price | 1.25 USD |
| Previous Close | 24.33 USD |
| Open | 24.2 USD |
| Bid | 0 USD x 1000 |
| Ask | 0 USD x 900 |
| Day's Range | 23.37 - 24.72 USD |
| 52 Week Range | 6.81 - 36.64 USD |
| Volume | 671.93K USD |
| Avg. Volume | 727.37K USD |
| Market Cap | 1.38B USD |
| Beta (5Y Monthly) | 1.403225 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -3.47 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 46.85 USD |
PLRX Valuation Measures
| Enterprise Value | 877.15M USD |
| Trailing P/E | N/A |
| Forward P/E | -7.002994 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 141.65317 |
| Price/Book (mrq) | 2.4551272 |
| Enterprise Value/Revenue | 89.798 |
| Enterprise Value/EBITDA | -6.298 |
Trading Information
Pliant Therapeutics Stock Price History
| Beta (5Y Monthly) | 1.403225 |
| 52-Week Change | 229.90% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 36.64 USD |
| 52 Week Low | 6.81 USD |
| 50-Day Moving Average | 24.28 USD |
| 200-Day Moving Average | 24.18 USD |
PLRX Share Statistics
| Avg. Volume (3 month) | 727.37K USD |
| Avg. Daily Volume (10-Days) | 506.89K USD |
| Shares Outstanding | 59.16M |
| Float | 45.16M |
| Short Ratio | 5.63 |
| % Held by Insiders | 6.67% |
| % Held by Institutions | 79.01% |
| Shares Short | 5.95M |
| Short % of Float | 10.25% |
| Short % of Shares Outstanding | 10.06% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -1444.34% |
| Gross Margin | 100.00% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -22.18% |
| Return on Equity (ttm) | -36.092% |
Income Statement
| Revenue (ttm) | 9.77M USD |
| Revenue Per Share (ttm) | 0.21 USD |
| Quarterly Revenue Growth (yoy) | 6.60% |
| Gross Profit (ttm) | 9.69M USD |
| EBITDA | -139264000 USD |
| Net Income Avi to Common (ttm) | -132769000 USD |
| Diluted EPS (ttm) | -3.04 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 577.31M USD |
| Total Cash Per Share (mrq) | 9.76 USD |
| Total Debt (mrq) | 15.19M USD |
| Total Debt/Equity (mrq) | 2.7 USD |
| Current Ratio (mrq) | 25.406 |
| Book Value Per Share (mrq) | 9.527 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -104409000 USD |
| Levered Free Cash Flow (ttm) | -56702248 USD |
Profile of Pliant Therapeutics
| Country | United States |
| State | CA |
| City | South San Francisco |
| Address | 260 Littlefield Avenue |
| ZIP | 94080 |
| Phone | 650 481 6770 |
| Website | https://pliantrx.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 136 |
Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. The company's lead candidate is bexotegrast, an oral, small-molecule, dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase IIa trials for idiopathic pulmonary fibrosis and primary sclerosing cholangitis. It also develops PLN-1474, a small-molecule selective inhibitor of avß1 for the treatment of liver fibrosis associated with nonalcoholic steatohepatitis; PLN-101095, a dual inhibitor of integrins avß8 and avß1 for the treatment of solid tumors; and PLN-101325 for treatment of muscular dystrophies. Pliant Therapeutics, Inc. was incorporated in 2015 and is based in South San Francisco, California.
Q&A For Pliant Therapeutics Stock
What is a current PLRX stock price?
Pliant Therapeutics PLRX stock price today per share is 1.25 USD.
How to purchase Pliant Therapeutics stock?
You can buy PLRX shares on the NasdaqGS exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Pliant Therapeutics?
The stock symbol or ticker of Pliant Therapeutics is PLRX.
Which industry does the Pliant Therapeutics company belong to?
The Pliant Therapeutics industry is Biotechnology.
How many shares does Pliant Therapeutics have in circulation?
The max supply of Pliant Therapeutics shares is 61.24M.
What is Pliant Therapeutics Price to Earnings Ratio (PE Ratio)?
Pliant Therapeutics PE Ratio is now.
What was Pliant Therapeutics earnings per share over the trailing 12 months (TTM)?
Pliant Therapeutics EPS is -3.47 USD over the trailing 12 months.
Which sector does the Pliant Therapeutics company belong to?
The Pliant Therapeutics sector is Healthcare.
Pliant Therapeutics PLRX included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 15455.34 USD — |
-0.85
|
4.92B USD — | 14784.03 USD — | 16292.28 USD — | — - | 4.92B USD — |
| Nasdaq US 700 Small Cap Index NQUS700SC | 1888.28 USD — |
-2.61
|
— — | 1835.13 USD — | 2001.25 USD — | — - | — — |
| Nasdaq AlphaDEX Multi Cap Growt NQDXUSMLTCG | 2459.83 USD — |
-1.63
|
— — | 2369.22 USD — | 2594.76 USD — | — - | — — |
| NASDAQ Biotechnology NBI | 3808.02 USD — |
-2.46
|
— — | 3700.88 USD — | 3966.57 USD — | — - | — — |
| NASDAQ HealthCare IXHC | 854.98 USD — |
-1.7
|
— — | 828.4 USD — | 890 USD — | — - | — — |
| NASDAQ Global Select Market Com NQGS | 7569.67 USD — |
-0.74
|
— — | 7233.89 USD — | 7972.89 USD — | — - | — — |
| Stlmt ID NASDAQ Biotechnology NBX | 4153.28 USD — |
+1.21
|
— — | 4281.91 USD — | 4648.11 USD — | — - | — — |
- {{ link.label }} {{link}}